Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates

Guardant Health (GH) came out with a quarterly loss of $1.58 per share versus the Zacks Consensus Estimate of a loss of$ 0.93. This compares to loss of $1.36 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -69.89%. A quarter ago, it was expected that this provider of oncology testing services would post a loss of$ 0.93 per share when it actually produced a loss of $0.73, delivering a surprise of 21.51%.Over the last four quart ...